625 related articles for article (PubMed ID: 23886002)
1. Influenza virus resistance to antiviral therapy.
van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
Nguyen HT; Fry AM; Gubareva LV
Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
[TBL] [Abstract][Full Text] [Related]
3. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
[TBL] [Abstract][Full Text] [Related]
5. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
Huang L; Zhou JF; Wei H; Shu YL
Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
Puzelli S; Facchini M; Di Martino A; Fabiani C; Lackenby A; Zambon M; Donatelli I
Antiviral Res; 2011 Jun; 90(3):205-12. PubMed ID: 21514326
[TBL] [Abstract][Full Text] [Related]
7. A review of neuraminidase inhibitor susceptibility in influenza strains.
Spanakis N; Pitiriga V; Gennimata V; Tsakris A
Expert Rev Anti Infect Ther; 2014 Nov; 12(11):1325-36. PubMed ID: 25301229
[TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of Antiviral Resistance in Influenza.
Li TC; Chan MC; Lee N
Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935
[TBL] [Abstract][Full Text] [Related]
9. The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors.
Hurt AC; Okomo-Adhiambo M; Gubareva LV
Methods Mol Biol; 2012; 865():115-25. PubMed ID: 22528156
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase inhibitor resistance in influenza viruses.
Reece PA
J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
[TBL] [Abstract][Full Text] [Related]
12. Influenza virus resistance to neuraminidase inhibitors.
Samson M; Pizzorno A; Abed Y; Boivin G
Antiviral Res; 2013 May; 98(2):174-85. PubMed ID: 23523943
[TBL] [Abstract][Full Text] [Related]
13. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
[TBL] [Abstract][Full Text] [Related]
14. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
[TBL] [Abstract][Full Text] [Related]
15. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.
Monto AS; McKimm-Breschkin JL; Macken C; Hampson AW; Hay A; Klimov A; Tashiro M; Webster RG; Aymard M; Hayden FG; Zambon M
Antimicrob Agents Chemother; 2006 Jul; 50(7):2395-402. PubMed ID: 16801417
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
17. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
[TBL] [Abstract][Full Text] [Related]
18. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
Hurt AC; Ho HT; Barr I
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
[TBL] [Abstract][Full Text] [Related]
19. Secondary substitutions in the hemagglutinin and neuraminidase genes associated with neuraminidase inhibitor resistance are rare in the Influenza Resistance Information Study (IRIS).
Roosenhoff R; Schutten M; Reed V; Clinch B; van der Linden A; Fouchier RAM; Fraaij PLA
Antiviral Res; 2021 May; 189():105060. PubMed ID: 33713731
[TBL] [Abstract][Full Text] [Related]
20. Antivirals and influenza: frequency of resistance.
Monto AS
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
